-transparent.png){kind=logo}
A 46 year woman with severe long-lasting SLE received an autologous bone marrow transplantation utilising CD34+ haematopoietic progenitors following a 3log T-lymphocyte depletion. The immunosuppressive regimen (conditioning) consisted of 15mg/kg Thiotepa followed by 100 mg/kg of cyclophosphamide over 2d. Granulocytic recovery was aided by G-CSF. The post-transplant course was uneventful, and a good clinical and immunologic remission (ANA negativisation) was achieved. This is the first case of SLE having received an autologous progenitor cell transplant for the autoimmune disease by itself, unaccompanied by a haematologic condition requiring transplantation. The potential, advantages and limits of this procedure, which are currently being explored worldwide, are briefly discussed.
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
January 2004,
Lupus,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
January 2004,
Lupus,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
December 2013,
Clinical rheumatology,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
October 2016,
Zeitschrift fur Rheumatologie,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
January 2004,
Lupus,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
March 2013,
Lupus,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
January 2012,
Clinical & developmental immunology,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
December 1997,
The New England journal of medicine,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
May 2000,
Rheumatic diseases clinics of North America,
A M Marmont, and
M T van Lint, and
F Gualandi, and
A Bacigalupo
June 2004,
Best practice & research. Clinical haematology,
